- France
- Italy
- United Kingdom
- Germany
- Switzerland
- Netherlands
- Belgium
- Ireland
- Spain
- Denmark
- Sweden
- United States
About
Sofinnova Partners is a Paris-based life sciences venture capital firm with offices in London and Milan. MD Start IV invests across France, Italy, the United Kingdom, Germany, Switzerland, the Netherlands, Belgium, Ireland, Spain, Denmark, Sweden and the United States. The fund supports founders at pre-seed and seed stages and closed at €82M.
Sofinnova MD Start is a medtech acceleration fund that creates and finances early-stage companies developing breakthrough therapeutic medical devices. It works directly with clinicians to turn innovative ideas into companies, combining company building with seed-stage capital. The fund differentiates itself through a team of serial medtech entrepreneurs and Sofinnova Partners' long record in European life sciences.
Sofinnova Partners was founded in 1972 in Paris, France, has offices in London and Milan, and has backed more than 500 life sciences companies. The MD Start strategy is led by Partners Anne Osdoit, Cécile Dupont and Mano Iyer, a team of serial medtech entrepreneurs, with Gérard Hascoët as Venture Partner and Antoine Papiernik as firm Chairman and Managing Partner. MD Start has created and financed companies including Moon Surgical, SafeHeal, CorWave, LimFlow and preCARDIA, which was acquired by Abiomed. MD Start IV closed at €82M, following the €63M MD Start III.
Sofinnova Partners Contacts Information